DSM and Firmenich’s mooted 2023 ‘Merger of Equals’ will create a nutrition, food ingredients and fragrances behemoth with 277 years of collective business experience and a combined annual revenue pushing towards €12 billion (£10.2bn).
Firmenich and DSM have revealed plans to merge the two companies in a move that they believe will create an ‘unparalleled’ leader in nutrition, beauty and wellbeing.
DSM has today (31 March) agreed to acquire the flavour and fragrance (F&F) business of US-based biotech firm Amyris, extending its portfolio with bio-based ingredients for the flavor and fragrance and cosmetics industries.
DSM will use its global reach to drive its latest acquisition - fish-sourced omega-3 leader, Ocean Nutrition Canada, beyond its core North American market – but sees opportunities in generic drugs that may prove more lucrative.
